These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11700425)

  • 1. Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease.
    Buchhorn R; Wessel A; Hulpke-Wette M; Bürsch J; Werdan K; Loppnow H
    Crit Care Med; 2001 Nov; 29(11):2208-10. PubMed ID: 11700425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
    Loppnow H; Werdan K; Werner C
    Auton Autacoid Pharmacol; 2002 Apr; 22(2):83-92. PubMed ID: 12568125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol.
    Buchhorn R; Hulpke-Wette M; Hilgers R; Bartmus D; Wessel A; Bürsch J
    Int J Cardiol; 2001 Jul; 79(2-3):167-73. PubMed ID: 11461738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.
    Seghaye MC; Duchateau J; Bruniaux J; Demontoux S; Détruit H; Bosson C; Lecronier G; Mokhfi E; Serraf A; Planché C
    Crit Care Med; 1997 Jun; 25(6):1063-70. PubMed ID: 9201062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts.
    Buchhorn R; Bartmus D; Siekmeyer W; Hulpke-Wette M; Schulz R; Bürsch J
    Am J Cardiol; 1998 Jun; 81(11):1366-8. PubMed ID: 9631979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease.
    Afify MF; Mohamed GB; El-Maboud MA; Abdel-Latif EA
    J Trop Pediatr; 2009 Dec; 55(6):388-92. PubMed ID: 19491251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity.
    van Riemsdijk-van Overbeeke IC; Baan CC; Niesters HG; Hesse CJ; Loonen EH; Balk AH; Maat AP; Weimar W
    Eur Heart J; 1999 Jun; 20(11):833-40. PubMed ID: 10329082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma nitric oxide products correlate with cardiac index of congenital heart disease.
    Takaya J; Ikemoto Y; Teraguchi M; Nogi S; Kobayashi Y
    Pediatr Cardiol; 2000; 21(4):378-81. PubMed ID: 10865019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
    Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
    Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level.
    Saitoh M; Osanai T; Kamada T; Matsunaga T; Ishizaka H; Hanada H; Okumura K
    Heart Vessels; 2003 Sep; 18(4):177-82. PubMed ID: 14520484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-Blockers in Children with Congenital Heart Disease Before a Corrective Procedure.
    Buchhorn R
    Rev Recent Clin Trials; 2014; 9(2):61-3. PubMed ID: 25198740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-adrenoceptor antagonist propranolol counteracts anti-inflammatory effects of isoflurane in rat endotoxemia.
    Boost KA; Flondor M; Hofstetter C; Platacis I; Stegewerth K; Hoegl S; Nguyen T; Muhl H; Zwissler B
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):900-8. PubMed ID: 17635398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass.
    el-Barbary M; Khabar KS
    Crit Care Med; 2002 Aug; 30(8):1712-6. PubMed ID: 12163781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium.
    Irwin MW; Mak S; Mann DL; Qu R; Penninger JM; Yan A; Dawood F; Wen WH; Shou Z; Liu P
    Circulation; 1999 Mar; 99(11):1492-8. PubMed ID: 10086975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-alpha levels in patients with ischemic heart disease.
    Djordjevic VB; Stojanovic I; Cosic V; Zvezdanovic L; Deljanin-Ilic M; Dimic S; Kundalic B; Cvetkovic T; Jevtovic-Stoimenov T
    Clin Chem Lab Med; 2008; 46(8):1149-55. PubMed ID: 18605955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.
    Kiettisanpipop P; Lertsapcharorn P; Chotivittayatarakorn P; Poovorawan Y
    J Med Assoc Thai; 2007 Oct; 90(10):2053-7. PubMed ID: 18041423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypoxia-inducible factor HIF-1 promotes intramyocardial expression of VEGF in infants with congenital cardiac defects.
    Qing M; Görlach A; Schumacher K; Wöltje M; Vazquez-Jimenez JF; Hess J; Seghaye MC
    Basic Res Cardiol; 2007 May; 102(3):224-32. PubMed ID: 17268888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.